Massachusetts Financial Services Co. MA Sells 8,047 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA)

Massachusetts Financial Services Co. MA trimmed its position in Sana Biotechnology, Inc. (NASDAQ:SANAFree Report) by 0.8% during the third quarter, HoldingsChannel.com reports. The firm owned 1,060,140 shares of the company’s stock after selling 8,047 shares during the quarter. Massachusetts Financial Services Co. MA’s holdings in Sana Biotechnology were worth $4,103,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of SANA. Swiss National Bank lifted its holdings in shares of Sana Biotechnology by 7.9% in the first quarter. Swiss National Bank now owns 89,300 shares of the company’s stock valued at $738,000 after purchasing an additional 6,500 shares in the last quarter. MetLife Investment Management LLC lifted its holdings in shares of Sana Biotechnology by 57.0% in the first quarter. MetLife Investment Management LLC now owns 48,321 shares of the company’s stock valued at $399,000 after purchasing an additional 17,543 shares in the last quarter. Rhumbline Advisers lifted its holdings in shares of Sana Biotechnology by 6.5% in the first quarter. Rhumbline Advisers now owns 90,696 shares of the company’s stock valued at $749,000 after purchasing an additional 5,518 shares in the last quarter. BlackRock Inc. lifted its holdings in shares of Sana Biotechnology by 8.4% in the first quarter. BlackRock Inc. now owns 6,470,876 shares of the company’s stock valued at $53,451,000 after purchasing an additional 500,173 shares in the last quarter. Finally, XTX Topco Ltd bought a new stake in shares of Sana Biotechnology in the first quarter valued at about $86,000. 68.37% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Separately, HC Wainwright upgraded Sana Biotechnology from a “neutral” rating to a “buy” rating and set a $12.00 price target on the stock in a report on Tuesday, January 16th.

Read Our Latest Report on Sana Biotechnology

Sana Biotechnology Trading Up 5.0 %

SANA opened at $6.47 on Monday. Sana Biotechnology, Inc. has a 52-week low of $2.74 and a 52-week high of $9.15. The business’s 50-day simple moving average is $5.00 and its 200 day simple moving average is $4.59.

Sana Biotechnology Profile

(Free Report)

Sana Biotechnology, Inc, a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others.

Featured Stories

Want to see what other hedge funds are holding SANA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sana Biotechnology, Inc. (NASDAQ:SANAFree Report).

Institutional Ownership by Quarter for Sana Biotechnology (NASDAQ:SANA)

Receive News & Ratings for Sana Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sana Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.